Clinical Trial Update: The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Clinical trial update describing a Phase 4 study evaluating nitazoxanide, interferon alfa, and ribavirin for hepatitis C in patients with type 2 diabetes. The r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Type 2 Diabetes Mellitus

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Nitazoxanide (nitazoxanide)
• Ribavirin (ribavirin)

Snippet

Sponsor: Services Institute of Medical Sciences, Pakistan | Conditions: Hepatitis C, Chronic, DIABETES MELLITUS Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2013-04-17